openPR Logo
Press release

Fibromyalgia - Drug Pipeline Landscape, 2022

08-04-2022 09:58 AM CET | Health & Medicine

Press release from: Global Insight Services

Fibromyalgia - Drug Pipeline Landscape

Fibromyalgia - Drug Pipeline Landscape

Fibromyalgia is a is a common chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep, memory and cognitive issues. Researchers reported that repeated nerve stimulation causes the brain and spinal cord of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD.

Fibromyalgia can be diagnosed if the patient had widespread pain for 3 months or longer. Healthcare professionals use a process of elimination to diagnose fibromyalgia, for concluding that no other condition is causing the pain. Healthcare professionals may rule out other conditions that may have similar symptoms with some tests including complete blood count, Rheumatoid factor, thyroid function tests, anti-nuclear antibody, cyclic citrullinated peptide test etc.

Read more about Fibromyalgia - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/

Report Highlights:

Global Insight Service's, Fibromyalgia - Drug Pipeline Landscape, 2022 report provides an overview of the Fibromyalgia pipeline drugs. This report covers detailed insights on Fibromyalgia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Fibromyalgia pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31036/

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Key Players:

- Aardvark Therapeutics Inc
- Aptinyx
- Astellas Pharma Inc
- Cortene Inc
- Shanghai lvdao pharmaceutical technology co., Ltd
- Pfizer
- Tonix Pharmaceuticals, Inc.
- TRYP Therapeutics

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31036/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibromyalgia - Drug Pipeline Landscape, 2022 here

News-ID: 2697716 • Views:

More Releases from Global Insight Services

U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 to 2033
U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 …
Market Definition An RTD cocktail is a pre-mixed alcoholic beverage that is typically sold in a can or bottle. RTD cocktails are convenient because they require no additional mixing or preparation, making them ideal for parties or other events where alcohol will be served. There are a variety of RTD cocktails available, including popular options such as Moscow Mules, Margaritas, and Bloody Marys. RTD cocktails are typically made with lower-quality alcohol,
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Forecast 2033
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Fore …
Market Definition A space semiconductor is a type of semiconductor device that is designed to function in extreme conditions found in outer space. Space semiconductors must be able to withstand high levels of radiation and extreme temperatures, as well as the vacuum of space. Space semiconductors are used in a variety of space-based applications, including satellites, spacecraft, and telescopes. They are also used in space exploration missions, such as the Mars
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Mühlbauer Group, Primekey Solutions Ab, Thales Group, Safran
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Müh …
Market Definition The E-passport Market represents a transformative shift in travel documentation, offering enhanced security and efficiency compared to traditional passports. Also known as biometric passports, E-passports incorporate a microprocessor chip containing the holder's biometric information, such as fingerprints and facial recognition data, along with personal details. This technology not only mitigates the risk of identity theft and fraud but also expedites border control processes by enabling automated authentication. Market Outlook The E-passport
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research Study, Trends, Development Status, Opportunities, Future Plans, Competitive Landscape And Growth By Forecast 2033
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research …
Market Definition The Oligonucleotide Synthesis Market is a vital component in the biotechnology and pharmaceutical industries, providing customized strands of DNA or RNA sequences for various applications such as genetic research, diagnostics, and therapeutic development. This market encompasses a range of synthesis technologies, including solid-phase synthesis and enzymatic methods, allowing researchers to tailor oligonucleotides with precision. As advancements in genomics, personalized medicine, and synthetic biology drive demand for high-quality oligonucleotides, the

All 5 Releases


More Releases for Fibromyalgia

Fibromyalgia Treatment Market 2022 | Increased Morbidity of Fibromyalgia Along w …
According to Precision Business Insights (PBI), the latest report, the Fibromyalgia Treatment market is expected to be valued at USD 3,017.9 million in 2022, growing at an 3.8% CAGR from 2022 to 2028. Fibromyalgia treatment market analysis projects that the increased prevalence of fibromyalgia and its related complication compelled the introduction of targeted & precise treatment methods for fibromyalgia. Also, the increase in awareness about fibromyalgia will give the required
Fibromyalgia Treatment Ingredient Market | 2021 Trends, Size, Share
The global fibromyalgia treatment market size is expected to reach USD 1,414.4 million by 2027, exhibiting a CAGR of 9.2% during the forecast period. Fibromyalgia Treatment Ingredient Industry is segmentedBy Product Type (Single Energy Mode, Dual Energy Mode), By Vehicle Type (Passenger Cars, Commercial Vehicles) and regional forecast 2021-2027 Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/fibromyalgia-treatment-market-105016 Strong Pipeline Products to Augment Growth The prominent companies are focused on introducing innovative therapies
Fibromyalgia Treatment Market Global Industry Insights 2018-2026
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms
Anticonvulsant Market for Fibromyalgia Optimistic Opportunities 2025
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Chinese Fibromyalgia Market Research Report- Forecast to 2022
Market Scenario: Fibromyalgia syndrome is a condition characterized by widespread musculoskeletal pain. Patients with fibromyalgia may also have muscle stiffness, increased sensitivity to pain, problems with mental processes, fatigue, irritable bowel syndrome (IBS), and others. As symptoms of fibromyalgia syndrome mimic other chronic diseases, therefore its diagnosis takes a long time. According to a study published in Arthritis Research & Therapy journal in 2017, in Taiwan, the risk of coronary heart
Fibromyalgia Therapeutics - Pipeline Analysis 2018
Fibromyalgia therapeutic pipeline is expected to experience a positive trend in the coming years. Prevalence of fibromyalgia is increasing due to very large number of patients suffering from lifestyle disease, psychological stress, trauma, tension, headaches, anxiety and depression. Some of the significant factors driving the pipeline for fibromyalgia include rising prevalence of fibromyalgia and the increasing health awareness among the population, globally. According to the National Fibromyalgia and Chronic Pain